China-Biotics, Inc. released its Q3 financial report, showing that, compared to last’s years Q3, revenues climbed 33% to $15.8 million while net income rose 40% to $5.7 million. The company, which makes probiotic products, attributed its improved performance to a combination of new products and a change in the sales mix as China-Biotics selectively raised its prices. It also increased its Shining retail outlets to 107 from 27 a year ago. More details...

Stock Symbol: (NSDQ: CHBT)